Sign In
Buy ARGX
$813.14
+10.97 (+1.37%)
At Close: Jun 03, 2026
argenx Announces Results of Annual General Meeting of Shareholders
04:01pm, Wednesday, 28'th May 2025
May 28, 2025 – 10:01 PM C ET
EXEL vs. ARGX: Which Stock Is the Better Value Option?
12:41pm, Friday, 23'rd May 2025
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Exelixis (EXEL) and argenex SE (ARGX). But which of these two stocks offers value investors a better bang for
Argenx (ARGX) Upgraded to Buy: Here's Why
01:05pm, Monday, 12'th May 2025
Argenx (ARGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Argenx Q1 Earnings: Less Than Perfect Report Gets Punished
08:02am, Friday, 09'th May 2025
Shares of argenx declined yesterday as Vyvgart missed investors' expectations. Vyvgart saw the usual negative seasonal headwinds in the U.S. in the first quarter that were further exacerbated by the M
argenx SE (ARGX) Q1 2025 Earnings Call Transcript
08:16pm, Thursday, 08'th May 2025
argenx SE (NASDAQ:ARGX ) Q1 2025 Results Conference Call May 8, 2025 8:30 AM ET Company Participants Beth DelGiacco - Vice President, Corporate Communications and Investor Relations Tim Van Hauwermeir
Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble
08:55am, Thursday, 08'th May 2025
Argenx stock tumbled Thursday after its drug, Vyvgart, beat sales expectations. But the beat wasn't strong enough for investors.
argenx Reports First Quarter 2025 Financial Results and Provides Business Update
01:00am, Thursday, 08'th May 2025
$790 million in first quarter global product net sales First patients treated with VYVGART Hytrulo pre-filled syringe for self-injection in US and Germany CIDP global expansion with positive CHMP opin
AZN or ARGX: Which Is the Better Value Stock Right Now?
12:46pm, Tuesday, 06'th May 2025
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Astrazeneca (AZN) or argenex SE (ARGX). But which of these two stocks offers value investors
argenx to Present at BofA Securities 2025 Health Care Conference
01:00am, Tuesday, 06'th May 2025
May 6, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ann
argenx to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025
01:00am, Thursday, 01'st May 2025
May 1, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ann
Argenx Stock Extends Rally In A Base As Earnings Loom
01:06pm, Wednesday, 30'th Apr 2025
Argenx stock is rising Wednesday as the major indexes sell off. The autoimmune disease treatment stock is climbing in an early-stage base.
VYVGART ® is first-and-only targeted IgG Fc-antibody fragment for CIDP First novel mechanism of action for CIDP treatment in more than 30 years CHMP positive opinion based on ADHERE data, the largest
Wall Street Analysts Believe Argenx (ARGX) Could Rally 25.8%: Here's is How to Trade
10:55am, Thursday, 24'th Apr 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 25.8% in Argenx (ARGX). While the effectiveness of this highly sought-after metric is questionable, the positiv
JAZZ vs. ARGX: Which Stock Is the Better Value Option?
12:40pm, Thursday, 17'th Apr 2025
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and argenex SE (ARGX). But which of these two stocks presents investors with the b
Argenx (ARGX) Moves 4.4% Higher: Will This Strength Last?
09:10am, Tuesday, 15'th Apr 2025
Argenx (ARGX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the
